Exploring olive oil compounds oleuropein and hydroxytyrosol as potential treatments for neuroblastoma

FHS
March 15, 2024
12:15 pm

The therapeutic potential of oleuropein (OLE) and hydroxytyrosol (HT) from olive oil.

Second Drug for Geographic Atrophy Gets Green Light From FDA

The FDA approved avacincaptad pegol (Izervay) for geographic atrophy secondary to age-related macular degeneration (AMD), Iveric Bio announced. A complement C5 inhibitor, avacincaptad pegol significantly

August 8, 2023

COVID-19 causes lasting cognitive impairment tied to brain injury markers

Researchers found that COVID-19 patients experienced widespread cognitive deficits one year post-hospitalization, associated with elevated brain injury markers and reduced brain volume. Cognitive recovery plateaued

September 26, 2024

Virtual reality can help doctors to handle difficult conversations with patients

With ever-growing pressures on the NHS, dealing with angry or frustrated patients and their relatives has become increasingly common for those working in healthcare.

June 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.